Category: Uncategorized

Resivant Medical Receives U.S. Patent Protecting Novel Single-Lever, Single-Handed Applicator at the Core of the Cutiva™ PLUS Skin Closure System

September 22, 2026

AKRON, Ohio, Sept. 22, 2026 /PRNewswire/ — Resivant Medical announced today that the U.S. Patent and Trademark Office has issued Patent No. 12,678,148, covering the novel single-lever, single-handed applicator design at the core of the Cutiva™ PLUS Skin Closure System. The patent protects the mechanism that allows clinicians to start, control, and stop the flow of adhesive using a single lever, without repositioning the hand or device.

RNA therapy may help preserve muscle during GLP-1 weight loss

September 19, 2026

In mice, adding the therapy to semaglutide led to greater loss of weight and fat while preserving more lean mass

Augmented eye clinic shows why AI-native systems work where standalone algorithms don’t

September 16, 2026

AI in eye care is set to take a new leap with an AI-native rather than assisted approach. Researchers have developed a new tool that moves beyond the conventional model of deploying AI as isolated, standalone tools for individual tasks by bringing together a network of specialized AI software agents that can operate across every stage of a patient’s care pathway.

Piezo Direct Develops Mesh Piezo Atomizer for Inhalation Applications

September 15, 2026

Safety-driven design eliminates laser-drilling debris and holds hole diameter at 2.0 microns

Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker

September 15, 2026

Abbott (NYSE: ABT) announced today that the FDA has approved the smallest version yet of its Aveir leadless pacemakers.

Not all colonoscopies are the same. New AI tool audits them at scale.

September 8, 2026

Study of 19,000 colonoscopies shows AI can accurately assess quality metrics from procedure videos

Blocking a microRNA reverses deadly lung disease in multiple models

September 2, 2026

Researchers blocked a naturally occurring molecule to reverse pulmonary arterial hypertension in preclinical models, a finding that could point to a new treatment approach for people with a rare and often fatal lung disease.

Stress proteins actively sustain joint inflammation in osteoarthritis, study finds

August 31, 2026

Why do some joints remain chronically inflamed in osteoarthritis and other rheumatic diseases?

Abbott’s next-generation Amulet LAA occlusion device earns CE Mark

August 27, 2026

Abbott’s (NYSE: ABT) Amulet 360 left atrial appendage (LAA) occlusion device received CE mark, the company announced today.

Gut bacteria may communicate differently with the human body in patients with Parkinson’s disease

August 26, 2026

A new study from the University of Oulu suggests that gut bacteria may send different biological signals in Parkinson’s disease. The findings add to growing evidence that changes in the gut could be linked to Parkinson’s disease and may eventually help researchers identify new underlying mechanisms for the condition.

Blog

- Uncategorized